Trump Unveils TrumpRx Website Selling Pfizer Drugs at Discounted Prices

President Trump announced the upcoming launch of a government-operated website called TrumpRx, designed to allow Americans to purchase prescription drugs directly at discounted prices. This initiative is part of a broader effort to align U.S. drug prices with those in other developed countries through most-favored-nation pricing. Pfizer has agreed to sell its drugs at prices comparable to international levels, promising an average 50% discount on the platform, with other pharmaceutical companies expected to follow. The website will serve patients not using insurance and aims to reduce the burden on American consumers who have historically subsidized drug development globally. While the specific drugs available on TrumpRx remain unclear, the initiative is seen as a significant shift in how branded therapies may be accessed, although some experts question its potential market impact given insurance dynamics. The administration portrays the move as a win for patients and American leadership, emphasizing the government's role in driving down drug costs.